Mile High Labs Innovates CBD Supply Chain to Deliver Increased Safety, Compliance and Confidence to Industry
April 25th, 2019
BOULDER, Colo., April 25, 2019 /PRNewswire/ — Mile High Labs, the largest extractor of CBD isolate in the world, today unveiled supply chain innovations aimed at further increasing transparency and bolstering consumer trust in the emerging CBD industry. With these advancements, Mile High Labs is setting new standards for what regulatory officials should demand of all processors.
“The rising popularity of CBD has been seen by some as an opportunity to capitalize on a lack of knowledge and regulations. As a result, our industry is at risk of bad actors,” said Jason Roth, CEO of Mile High Labs. “These major developments in the Mile High Labs Supply Chain represent our steadfast commitment not only to safety and transparency, but to the technological and regulatory advancement of the entire industry.”
The announcement comes shortly after the March launch of the Mile High Labs Client Portal, which uses blockchain technology to provide on-demand compliance documentation, including Certificates of Analysis, Safety Data Sheets and Harvest Information. These documents enable customers to review data from product testing and trace the origin of the product to the corresponding hemp and production batches.
“Blockchain technology helps us aggregate data from all of the systems within our supply chain to ensure no information gets lost or altered as product moves from farm to lab and ultimately into the hands of the customer,” said Sébastien Pasquali, Supply Chain Solutions Manager at Mile High Labs.
The Company has partnered with Chain.io to utilize their leading supply chain connectivity platform, Vault, which leverages the power of the blockchain to provide strong, auditable proof for documentation authorization and audits. Vault lets Mile High Labs upload documents in any format, and once uploaded, Chain.io writes a hash of the document related information which is then sent to a public domain.
As the first CBD client of Chain.io, Mile High Labs is capitalizing on the opportunity to bring new confidence in their supply chain to this emerging industry.
“In more traditional industries, such as food production and pharmaceuticals, there are legacy systems and long-established ways of thinking,” said Brian Glick, CEO of Chain.io. “Because Mile High Labs is building something from scratch, they have the opportunity to do things right the first time and set an example for the rest of the industry to follow.”
With new CBD legislation expected in the near future and substantial growth in international trade of CBD, delivering compliance, transparency and regulation requires innovation on all fronts, including logistics and operations. Other initiatives within Mile High Labs to advance these efforts include:
- Pharmaceutical-grade packaging to protect the integrity of CBD ingredients
- Sensors to detect location, g-force, tilt, light, temperature and humidity, and provide real-time tracking to customers
- Tamper-evident seals to ensure any unwanted modifications to the product are obvious upon arrival
“Mile High Labs is providing concrete, factual answers to some of the most prevalent questions that CBD consumers have: Where does my CBD come from? Has it been tampered with? Can I trust the source?” adds Roth. “In an ever evolving regulatory landscape, our advanced supply chain protects the integrity of our brand and products. We want to ensure that our customers are getting exactly what they expect and depend on—genuine, high quality Mile High Labs CBD.”
About Mile High Labs
Mile High Labs is an industrial-scale CBD ingredient manufacturer offering reliable delivery of bulk CBD and co-packing services to the world’s leading consumer brands. With an end-to-end GMP certified extraction facility and extensive network of contracted cultivators, Mile High Labs supplies high-quality, high-volume CBD orders year round. Mile High Labs extracts exclusively from industrial hemp flower material. To learn more about Mile High Labs, visit www.milehighlabs.com.
Chain.io delivers smarter and faster data integration via their cutting-edge Supply Chain Connectivity Platform. Their fully managed integration services allow Logistics Service Providers, Shippers, and Technology Firms to work together more efficiently utilizing legacy, modern, and next generation technologies. Specialties include Blockchain, as well as complex EDI and API integrations. Chain.io is headquartered in Philadelphia, PA. For more information, contact [email protected].
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
Follow Us on Social Media
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.